PRESS RELEASE MANDARIN CAPITAL PARTNERS ACQUIRES MIPHARM SPA The goal is to support the international growth of the Company, leveraging Mipharm as a growth platform in the CDMO industry Milan, 06th December 2016 – Mandarin Capital Partners II (MCP II) has successfully acquired a majority stake in the share capital...
Archive for month: April, 2017
Recent Posts
- Cassiopea Partners advised Mandarin Capital Partners on the sale of Mipharm to Alto Partners
- Cassiopea Partners advises iCON Infrastructure in the acquisition of Sestrieres S.p.A., one of the largest ski resorts in Italy
- Cassiopea Partners advises White Bridge Investments and Biofarma Group in the acquisition of a majority stake in the Finished Products Division of Giellepi S.p.A., leader in the development of nutraceutical dietary supplements and medical devices
- Cassiopea Partners advises Bregal Unternehmerkapital in the acquisition of a majority stake in Safety21, a leader in the Smart Road and Smart City space
- Cassiopea Partners assisted Gruppo Lunelli in the acquisition of Cedral Tassoni
Archives
- March 2022
- January 2022
- December 2021
- October 2021
- May 2021
- January 2021
- December 2020
- November 2020
- September 2020
- August 2020
- July 2019
- July 2018
- June 2018
- January 2018
- December 2017
- October 2017
- July 2017
- June 2017
- April 2017
- February 2016
- July 2015
- March 2014
- December 2013
- June 2013
- September 2012